https://idataresearch.com/wp-content/uploads/2016/04/ReportIcon-Cell-MC.jpg

Orthopedic Cell Therapy Market Size, Share, and COVID-19 Impact Analysis | Global | 2023-2029 | MedCore | Includes: Platelet-rich Cell Therapy and 1 more

  • Year: 2023
  • Scope: 10 Years
  • Region: Global
  • Pages: 67
  • Published Date: 12/30/2022
  • Type: MedCore

Overall, the global orthopedic cell therapy market was valued at $470 million in 2022. This is expected to increase over the forecast period at a CAGR of 7.2% to reach $760 million.

The full report suite on the global market for orthopedic cell therapy includes platelet-rich cell therapy and bone marrow cell therapy.

DATA TYPES INCLUDED

  • Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • Sports Medicine Procedure Volumes
  • Market Forecasts Until 2029, and Historical Data to 2022
  • Market Drivers & Limiters for each Sports Medicine market segment
  • Competitive Analysis with Market Shares for Each Segment
  • Recent Mergers & Acquisitions
  • Disease Overviews and Demographic Information
  • Company Profiles, Product Portfolios and SWOT for Top Competitors

 PROCEDURE NUMBERS

Aside from the decline and recovery during 2020 and 2022, associated with the delay and cancellation of elective procedures, the total number of orthopedic cell therapy procedures is projected to grow at a mid-single-digit rate over the forecast period.

GLOBAL ORTHOPEDIC CELL THERAPY MARKET INSIGHTS

global orthopedic cell therapy marketThe orthopedic cell therapy market continues to grow steadily year after year largely due to the rising number of BMAC units sold. The COVID-19 pandemic did impact this market, leading to an overall decrease in procedures in 2020 and a subsequent dip in market value. A rapid increase in market value was seen in 2022 in both the PRP and BMAC segments as the pandemic subsides, as patients who previously postponed surgeries were able to get elective surgeries again.

GLOBAL ORTHOPEDIC CELL THERAPY MARKET SHARE INSIGHTS

The global orthopedic bone cell therapy market is controlled by three main companies: Harvest Terumo, Zimmer Biomet, and Isto Biologics.

global orthopedic cell therapy

In 2022, Harvest Technologies was the leader in the orthopedic cell therapy market. Harvest Technologies products include Harvest® BMAC and Harvest® PRP. Harvest Technologies also has an adipose tissue concentrator, Harvest® AdiPrep®, and its Harvest® SmartPrep multicellular processing system, which is capable of handling bone marrow, blood and adipose tissue for concentration.

GLOBAL ORTHOPEDIC CELL THERAPY MARKET SEGMENTATION SUMMARY

  • Platelet-rich Cell Therapy Market
  • Bone Marrow Cell Therapy Market

RESEARCH SCOPE SUMMARY

Report Attribute Details
Regions North America (Canada, United States)
Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela)
Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.)
Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan,   Poland, Romania, Russia, Turkey, Ukraine)
Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates)
Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand,   Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam)
Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)
Base Year 2022
Forecast 2023-2029
Historical Data 2019-2022
Quantitative Coverage Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.
Qualitative Coverage COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.
Data Sources Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.

 

FREE Sample Report

Table of Contents:

Orthopedic Cell Therapy Market
7.1 Executive Summary
7.1.1 Global Orthopedic Cell Therapy Market Overview
7.1.2 Competitive Analysis
7.1.3 Regions Included
7.2 Introduction
7.2.1 Platelet-Rich Plasma
7.2.2 Concentrated Bone Marrow Aspirate
7.3 Procedure Numbers
7.3.1 Total Orthopedic Cell Therapy Procedures
7.3.2 Platelet-Rich Plasma Procedures
7.3.3 Bone Marrow Aspirate Concentrate Procedures
7.4 Market Overview
7.4.1 By Segment
7.4.2 By Region
7.5 Market Analysis and Forecast
7.5.1 Platelet-Rich Plasma Market
7.5.2 Bone Marrow Aspirate Concentrate Market
7.6 Drivers and Limiters
7.6.1 Market Drivers
7.6.2 Market Limiters
7.7 Competitive Market Share Analysis

Companies Included:

Harvest Terumo
Zimmer Biomet
Arthrex
Isto Biologics
Celling Biosciences
Exactech
Nuo Therapeutics
Others include: Adistem, BioCell, NuVasive, PromoCell, Regenexx, Takara Bio, ThermoGenesis, etc.

List of Charts

Chart 7‑1: Orthopedic Cell Therapy Market, Global, 2022 & 2029
Chart 7‑2: Orthopedic Cell Therapy Procedures, Global, 2022
Chart 7‑3: Orthopedic Cell Therapy Procedures by Segment, Global, 2019 – 2029
Chart 7‑4: Orthopedic Cell Therapy Device Market by Segment, Global, 2019 – 2029
Chart 7‑5: Orthopedic Cell Therapy Device Market by Region, Global, 2019 – 2029
Chart 7‑6: Leading Competitors, Orthopedic Cell Therapy Market, Global, 2022

List of Figures

Figure 7‑1: Orthopedic Cell Therapy Procedures by Segment, Global, 2019 – 2029
Figure 7‑2: Orthopedic Cell Therapy Procedures by Region, Global, 2019 – 2029
Figure 7‑3: Orthopedic Cell Therapy Procedures by Country, North America, 2019 – 2029
Figure 7‑4: Orthopedic Cell Therapy Procedures by Country, Latin America, 2019 – 2029 (1 of 2)
Figure 7‑5: Orthopedic Cell Therapy Procedures by Country, Latin America, 2019 – 2029 (2 of 2)
Figure 7‑6: Orthopedic Cell Therapy Procedures by Country, Western Europe, 2019 – 2029
Figure 7‑7: Orthopedic Cell Therapy Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2)
Figure 7‑8: Orthopedic Cell Therapy Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2)
Figure 7‑9: Orthopedic Cell Therapy Procedures by Country, Middle East, 2019 – 2029
Figure 7‑10: Orthopedic Cell Therapy Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3)
Figure 7‑11: Orthopedic Cell Therapy Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3)
Figure 7‑12: Orthopedic Cell Therapy Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3)
Figure 7‑13: Orthopedic Cell Therapy Procedures by Country, Africa, 2019 – 2029
Figure 7‑14: Orthopedic Platelet-Rich-Plasma Procedures by Region, Global, 2019 – 2029
Figure 7‑15: Orthopedic Platelet-Rich-Plasma Procedures by Country, North America, 2019 – 2029
Figure 7‑16: Orthopedic Platelet-Rich-Plasma Procedures by Country, Latin America, 2019 – 2029 (1 of 2)
Figure 7‑17: Orthopedic Platelet-Rich-Plasma Procedures by Country, Latin America, 2019 – 2029 (2 of 2)
Figure 7‑18: Orthopedic Platelet-Rich-Plasma Procedures by Country, Western Europe, 2019 – 2029
Figure 7‑19: Orthopedic Platelet-Rich-Plasma Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2)
Figure 7‑20: Orthopedic Platelet-Rich-Plasma Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2)
Figure 7‑21: Orthopedic Platelet-Rich-Plasma Procedures by Country, Middle East, 2019 – 2029
Figure 7‑22: Orthopedic Platelet-Rich-Plasma Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3)
Figure 7‑23: Orthopedic Platelet-Rich-Plasma Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3)
Figure 7‑24: Orthopedic Platelet-Rich-Plasma Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3)
Figure 7‑25: Orthopedic Platelet-Rich-Plasma Procedures by Country, Africa, 2019 – 2029
Figure 7‑26: Orthopedic Bone Marrow Aspirate Concentrate Procedures by Region, Global, 2019 – 2029
Figure 7‑27: Orthopedic Bone Marrow Aspirate Concentrate Procedures by Country, North America, 2019 – 2029
Figure 7‑28: Orthopedic Bone Marrow Aspirate Concentrate Procedures by Country, Latin America, 2019 – 2029 (1 of 2)
Figure 7‑29: Orthopedic Bone Marrow Aspirate Concentrate Procedures by Country, Latin America, 2019 – 2029 (2 of 2)
Figure 7‑30: Orthopedic Bone Marrow Aspirate Concentrate Procedures by Country, Western Europe, 2019 – 2029
Figure 7‑31: Orthopedic Bone Marrow Aspirate Concentrate Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2)
Figure 7‑32: Orthopedic Bone Marrow Aspirate Concentrate Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2)
Figure 7‑33: Orthopedic Bone Marrow Aspirate Concentrate Procedures by Country, Middle East, 2019 – 2029
Figure 7‑34: Orthopedic Bone Marrow Aspirate Concentrate Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3)
Figure 7‑35: Orthopedic Bone Marrow Aspirate Concentrate Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3)
Figure 7‑36: Orthopedic Bone Marrow Aspirate Concentrate Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3)
Figure 7‑37: Orthopedic Bone Marrow Aspirate Concentrate Procedures by Country, Africa, 2019 – 2029
Figure 7‑38: Orthopedic Cell Therapy Device Market by Segment, Global, 2019 – 2029 (US$M)
Figure 7‑39: Orthopedic Cell Therapy Device Market by Region, Global, 2019 – 2029 (US$M)
Figure 7‑40: Platelet-Rich Plasma Market, Global, 2019 – 2029
Figure 7‑41: Units Sold by Region, Platelet-Rich Plasma Market, Global, 2019 – 2029
Figure 7‑42: Average Selling Price by Region, Platelet-Rich Plasma Market, Global, 2019 – 2029 (US$)
Figure 7‑43: Market Value by Region, Platelet-Rich Plasma Market, Global, 2019 – 2029 (US$M)
Figure 7‑44: Bone Marrow Aspirate Concentrate Market, Global, 2019 – 2029
Figure 7‑45: Units Sold by Region, Bone Marrow Aspirate Concentrate Market, Global, 2019 – 2029
Figure 7‑46: Average Selling Price by Region, Bone Marrow Aspirate Concentrate Market, Global, 2019 – 2029 (US$)
Figure 7‑47: Market Value by Region, Bone Marrow Aspirate Concentrate Market, Global, 2019 – 2029 (US$M)
Figure 7‑48: Leading Competitors, Orthopedic Cell Therapy Market, Global, 2022

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Explore Options

Report Summary FREE

Orthopedic Cell Therapy Market Size, Share, and COVID-19 Impact Analysis | Global | 2023-2029 | MedCore | Includes: Platelet-rich Cell Therapy and 1 more

$4,995$8,995

The full report suite on the global market for orthopedic cell therapy includes platelet-rich cell therapy and bone marrow cell therapy.

  • 2023
  • 10 Years
  • Global
  • 12/30/2022
  • 67
  • MedCore
Clear
Request Sample Sheets Request Customization